PRESS RELEASE published on 09/11/2023 at 15:54, 1 year 2 months ago EQS-Adhoc: Epigenomics AG: Approval by the Extraordinary General Meeting of the acquisition of almost all assets and corresponding change of the statutory purpose of the Company
PRESS RELEASE published on 09/05/2023 at 17:20, 1 year 2 months ago Epigenomics AG: Pareto and Warburg publish analyst research reports
PRESS RELEASE published on 08/10/2023 at 08:00, 1 year 3 months ago Epigenomics AG publishes financial results for the first six months 2023
PRESS RELEASE published on 08/02/2023 at 10:36, 1 year 3 months ago EQS-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 5 : 1
PRESS RELEASE published on 07/24/2023 at 18:40, 1 year 3 months ago Epigenomics AG Announces Successful Agreement on the Acquisition of Significant Assets
PRESS RELEASE published on 07/24/2023 at 18:29, 1 year 3 months ago EQS-Adhoc: Epigenomics AG: Agreement on the Acquisition of Almost All Assets
PRESS RELEASE published on 06/12/2023 at 10:21, 1 year 5 months ago EQS-Adhoc: Epigenomics AG: Negotiations on the Acquisitions of Almost All Assets
PRESS RELEASE published on 05/31/2023 at 08:00, 1 year 5 months ago Epigenomics AG Reports Financial Results for the First Quarter of 2023
PRESS RELEASE published on 05/19/2023 at 18:00, 1 year 6 months ago Epigenomics AG: Member of the Executive Board and Chief Scientific Officer Andrew Lukowiak Resigns
PRESS RELEASE published on 05/19/2023 at 17:48, 1 year 6 months ago EQS-Adhoc: Epigenomics AG: Changes in the Management
Published on 11/21/2024 at 13:30, 34 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 34 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 28 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 49 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 6 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 44 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
